JAMA Network Open
Original Investigation
Pharmacy and Clinical Pharmacology
June 13, 2022
Joshua J . Fenton , MD, MPH; Elizabeth Magnan, MD, PhD; Iraklis Erik Tseregounis, PhD; Guibo Xing, PhD; Alicia L. Agnoli, MD, MPH, MHS; Daniel J. Tancredi, PhD
open access
JAMA Netw Open. 2022; 5(6):e2216726. doi: 10.1001/jamanetworkopen.2022.16726This cohort study assesses the longer-term risks of overdose or mental health crisis associated with opioid dose tapering.
JAMA
Comment & Response
February 15, 2022
Joshua J . Fenton , MD, MPH
JAMA. 2022; 327(7):687-687. doi: 10.1001/jama.2022.0323
JAMA
Original Investigation
August 3, 2021
Alicia Agnoli, MD, MPH, MHS; Guibo Xing, PhD; Daniel J. Tancredi, PhD; Elizabeth Magnan, MD, PhD; Anthony Jerant, MD; Joshua J . Fenton , MD, MPH
free access is active quiz
JAMA. 2021; 326(5):411-419. doi: 10.1001/jama.2021.11013This study examines whether there are associations between opioid dose tapering and subsequent rates of overdose and mental health crisis among patients prescribed stable, long-term, high-dose opioids.
JAMA Network Open
Original Investigation
Pharmacy and Clinical Pharmacology
November 15, 2019
Joshua J . Fenton , MD, MPH; Alicia L. Agnoli, MD, MPH, MHS; Guibo Xing, PhD; Lillian Hang, MBA, MPH; Aylin E. Altan, PhD; Daniel J. Tancredi, PhD; Anthony Jerant, MD; Elizabeth Magnan, MD, PhD
open access
JAMA Netw Open. 2019; 2(11):e1916271. doi: 10.1001/jamanetworkopen.2019.16271This cohort study characterizes US trends in opioid dose tapering among patients prescribed long-term opioids from 2008 to 2017 and identifies patient-level variables associated with tapering and a more rapid tapering rate.
JAMA Internal Medicine
Invited Commentary
September 1, 2019
Joy Melnikow, MD, MPH; Joshua J Fenton , MD, MPH
JAMA Intern Med. 2019; 179(9):1295-1296. doi: 10.1001/jamainternmed.2019.1037
JAMA
US Preventive Services Task Force
Evidence Report
May 8, 2018
Joshua J . Fenton , MD, MPH; Meghan S. Weyrich, MPH; Shauna Durbin, MPH; Yu Liu, MS; Heejung Bang, PhD; Joy Melnikow, MD, MPH
free access
JAMA. 2018; 319(18):1914-1931. doi: 10.1001/jama.2018.3712This systematic review to support the 2018 US Preventive Services Task Force Recommendation Statement on screening for prostate cancer summarizes published evidence on the benefits and harms of prostate cancer screening and treatment and the use of prebiopsy risk calculators to discriminate between men with and without high-risk cancer.
JAMA Internal Medicine
Original Investigation
January 1, 2018
Anthony Jerant, MD; Joshua J . Fenton , MD, MPH; Richard L. Kravitz, MD, MSPH; Daniel J. Tancredi, PhD; Elizabeth Magnan, MD, PhD; Klea D. Bertakis, MD, MPH; Peter Franks, MD
free access
JAMA Intern Med. 2018; 178(1):85-91. doi: 10.1001/jamainternmed.2017.6611This cross-sectional observational study examines how patient satisfaction with the clinician is associated with clinician denial of distinct types of patient requests, adjusting for patient characteristics.
JAMA Oncology
Original Investigation
January 1, 2017
Ronald M. Epstein, MD; Paul R. Duberstein, PhD; Joshua J . Fenton , MD, MPH; Kevin Fiscella, MD, MPH; Michael Hoerger, PhD; Daniel J. Tancredi, PhD; Guibo Xing, PhD; Robert Gramling, MD, DSc; Supriya Mohile, MD, MS; Peter Franks, MD; Paul Kaesberg, MD; Sandy Plumb, BS; Camille S. Cipri, BS; Richard L. Street Jr, PhD; Cleveland G. Shields, PhD; Anthony L. Back, MD; Phyllis Butow, PhD, MPH; Adam Walczak, PhD; Martin Tattersall, MD, ScD; Alison Venuti, BS; Peter Sullivan, MSW; Mark Robinson, MSW; Beth Hoh, MSW; Linda Lewis, RN; Richard L. Kravitz, MD, MSPH
free access
JAMA Oncol. 2017; 3(1):92-100. doi: 10.1001/jamaoncol.2016.4373This study describes the effectiveness of a combined intervention that included oncologist communication training and coaching for patients with advanced cancer and caregivers in improving patient-centered communication.
JAMA Oncology
Original Investigation
November 1, 2016
Robert Gramling, MD, DSc; Kevin Fiscella, MD, MPH; Guibo Xing, PhD; Michael Hoerger, PhD; Paul Duberstein, PhD; Sandy Plumb, BS; Supriya Mohile, MD, MS; Joshua J . Fenton , MD, MPH; Daniel J. Tancredi, PhD; Richard L. Kravitz, MD, MSPH; Ronald M. Epstein, MD
free access
JAMA Oncol. 2016; 2(11):1421-1426. doi: 10.1001/jamaoncol.2016.1861This survey study characterizes the frequency of differences in opinion about prognosis among patients with advanced cancer and their oncologists, and reasons for the differences.
JAMA Internal Medicine
Research Letter
Less Is More
March 1, 2016
Joshua J . Fenton , MD, MPH; John A. Robbins, MD, MSH; Anna Lee D. Amarnath, MD, MPH; Peter Franks, MD
free access
JAMA Intern Med. 2016; 176(3):391-393. doi: 10.1001/jamainternmed.2015.6020This cohort study estimates the incidence of osteoporosis overtreatment of women in a health system where DXA reports include T scores for anatomic sites that guidelines recommend against using as a basis for treatment.
JAMA Internal Medicine
Original Investigation
Less Is More
February 1, 2016
Joshua J . Fenton , MD, MPH; Richard L. Kravitz, MD, MSPH; Anthony Jerant, MD; Debora A. Paterniti, PhD; Heejung Bang, PhD; Donna Williams, MD; Ronald M. Epstein, MD; Peter Franks, MD
free access
JAMA Intern Med. 2016; 176(2):191-197. doi: 10.1001/jamainternmed.2015.6840This randomized clinical trial evaluates the effectiveness of a standardized patient–based intervention designed to enhance primary care physician patient-centeredness and skill in handling patient requests for low-value diagnostic tests.
JAMA Internal Medicine
Invited Commentary
November 1, 2015
Joshua J . Fenton , MD, MPH
JAMA Intern Med. 2015; 175(11):1837-1838. doi: 10.1001/jamainternmed.2015.5319
JAMA Internal Medicine
Research Letter
Less Is More
December 1, 2014
Joshua J . Fenton , MD, MPH; Christoph I. Lee, MD, MSHS; Guibo Xing, PhD; Laura-Mae Baldwin, MD, MPH; Joann G. Elmore, MD, MPH
free access
JAMA Intern Med. 2014; 174(12):2032-2034. doi: 10.1001/jamainternmed.2014.5410
JAMA Internal Medicine
Editor's Correspondence
July 23, 2012
Joshua J . Fenton , MD, MPH; Klea D. Bertakis, MD, MPH; Peter Franks, MD
Arch Intern Med. 2012; 172(14):1110-1114. doi: 10.1001/archinternmed.2012.2562
JAMA Internal Medicine
Original Investigation
March 12, 2012
Joshua J . Fenton , MD, MPH; Anthony F. Jerant, MD; Klea D. Bertakis, MD, MPH; Peter Franks, MD
free access
Arch Intern Med. 2012; 172(5):405-411. doi: 10.1001/archinternmed.2011.1662
JAMA Internal Medicine
Comments, Opinions, and Brief Case Reports
Health Care Reform
June 14, 2010
Joshua J . Fenton , MD, MPH; Susan Bartlett Foote, JD, MA; Pamela Green, PhD; Laura-Mae Baldwin, MD, MPH
Arch Intern Med. 2010; 170(11):987-989. doi: 10.1001/archinternmed.2010.104
JAMA Internal Medicine
Original Investigation
June 23, 2008
Anthony F. Jerant, MD; Joshua J . Fenton , MD, MPH; Peter Franks, MD
free access
Arch Intern Med. 2008; 168(12):1317-1324. doi: 10.1001/archinte.168.12.1317
JAMA Internal Medicine
Original Investigation
March 26, 2007
Joshua J . Fenton , MD, MPH; Yong Cai, PhD; Noel S. Weiss, MD, DrPH; Joann G. Elmore, MD, MPH; Roy E. Pardee, JD, MA; Robert J. Reid, MD, PhD; Laura-Mae Baldwin, MD, MPH
free access
Arch Intern Med. 2007; 167(6):580-585. doi: 10.1001/archinte.167.6.580
JAMA
Letters
September 24, 2003
Joshua J . Fenton , MD
JAMA. 2003; 290(12):1576-1576. doi: 10.1001/jama.290.12.1576-a